参考文献/References:
[1]Grifoen AW,Molema G. Angiogenesis:potentials for pharmacologic intervention in the treatment of cancer,cardiovascular diseases,and chronic infammation[J]. Pharmacol Rev,2000,52(2):237-268.
[2]Khaksar M,Sayyari M,Rezaie J,et al. High glucose condition limited the angiogenic/cardiogenic capacity of murine cardiac progenitor cells in in vitro and in vivo milieu[J]. Cell Biochem Funct,2018,36(7):346-356.
[3]Abdyazdani N,Nourazarian A,Charoudeh HN,et al. The role of morphine on rat neural stem cells viability,neuro-angiogenesis and neuro-steroidgenesis properties[J]. Neurosci Lett,2017,636:205-212.
[4]Akbari A,Jabbari N,Sharif R,et al. Free and hydrogel encapsulated exosome-based therapies in regenerative medicine[J]. Life Sci,2020,249:117447.
[5]Adams RH,Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis[J]. Nat Rev Mol Cell Biol,2007,8(6):464-478.
[6]Ahmadi M,Rezaie J. Tumor cells derived-exosomes as angiogenenic agents:possible therapeutic implications[J]. J Transl Med,2020,18(1):294.
[7]Eichhorn ME,Kleespies A,Angele MK,et al. Angiogenesis in cancer:molecular mechanisms,clinical impact[J]. Langenbecks Arch Surg,2007,392(3):371-379.
[8]Ladomery MR,Harper SJ,Bates DO. Alternative splicing in angiogenesis:the vascular endothelial growth factor paradigm[J]. Cancer Lett,2007,249(2):133-142.
[9]Tschuschke M,Kocherova I,Bryja A,et al. Inclusion biogenesis,methods of isolation and clinical application of human cellular exosomes[J]. J Clin Med,2020,9(2):436.
[10]Akbari A,Rezaie J. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia[J]. Stem Cell Res Ther,2020,11(1):356.
[11]Urbanelli L,Magini A,Buratta S,et al. Signaling pathways in exosomes biogenesis,secretion and fate[J]. Genes(Basel),2013,4(2):152-170.
[12]Zhang J,Chen C,Hu B,et al. Exosomes derived from human endothelial progenitor cells accelerate cutaneous wound healing by promoting angiogenesis through Erk1/2 signaling[J]. Int J Biol Sci,2016,12(12):1472-1487.
[13]Ertl G,Frantz S. Healing after myocardial infarction[J]. Cardiovasc Res,2005,66(1):22-32.
[14]Marbán E. Breakthroughs in cell therapy for heart disease:focus on cardiosphere-derived cells[J]. Mayo Clin Proc,2014,89(6):850-858.
[15]Kreke M,Smith RR,Marbán L,et al. Cardiospheres and cardiosphere-derived cells as therapeutic agents following myocardial infarction[J]. Expert Rev Cardiovasc Ther,2012,10(9):1185-1194.
[16]Ibrahim AG,Cheng K,Marbán E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy[J]. Stem Cell Reports,2014,2(5):606-619.
[17]Gallet R,Dawkins J,Valle J,et al. Exosomes secreted by cardiospherederived cells reduce scarring,attenuate adverse remodelling,and improve function in acute and chronic porcine myocardial infarction[J]. Eur Heart J,2017,38(3):201-211.
[18]Namazi H,Mohit E,Namazi I,et al. Exosomes secreted by hypoxic cardiospherederived cells enhance tube formation and increase pro-angiogenic miRNA[J]. J Cell Biochem,2018,119(5):4150-4160.
[19]Dougherty JA,Patel N,Kumar N,et al. Human cardiac progenitor cells enhance exosome release and promote angiogenesis under physoxia[J]. Front C ell D ev B iol,2020,8:130.
[20]Wang L,Jia Q,Xinnong C,et al. Role of cardiac progenitor cell-derived exosome-mediated microRNA-210 in cardiovascular disease[J]. J Cell Mol Med,2019,23(11):7124-7131.
[21]Youn SW,Li Y,Kim YM,et al. Modification of cardiac progenitor cell-derived exosomes by miR-322 provides protection against myocardial infarction through Nox2-dependent angiogenesis[J]. Antioxidants(Basel),2019,8(1):18.
[22]Yi M,Wu Y,Long J,et al. Exosomes secreted from osteocalcin-overexpressing endothelial progenitor cells promote endothelial cell angiogenesis[J]. Am J Physiol Cell Physiol,2019,317(5):932-941.
[23]Khan M,Nickolof E,Abramova T,et al. Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction[J]. Circ Res,2015,117(1):52-64.
[24]Kervadec A,Bellamy V,El Harane N,et al. Cardiovascular progenitor-derived extracellular vesicles recapitulate the benefcial efects of their parent cells in the treatment of chronic heart failure[J]. J Heart Lung Transplant,2016,35(6):795-807.
[25]Arslan F,Lai RC,Smeets MB,et al. Mesenchymal stem cell derived exosomes increase ATP levels,decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury[J]. Stem cell Res,2013,10(3):301-312.
[26]Burke J,Kolhe R,Hunter M,et al. Stem cellderived exosomes:a potential alternative therapeutic agent in orthopaedics[J]. Stem Cells Int,2016,2016:5802529.
[27]Mackie AR,Klyachko E,Thorne T,et al. Sonic hedgehog-modifed human CD34+ cells preserve cardiac function after acute myocardial infarction[J]. Circ Res,2012,111(3):312-321.
[28]Teng X,Chen L,Chen W,et al. Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-infammation[J]. Cell Physiol Biochem,2015,37(6):2415-2424.
[29]Kang K,Ma R,Cai W,et al. Exosomes secreted from CXCR4 overexpressing mesenchymal stem cells promote cardioprotection via Akt signaling pathway following myocardial infarction[J]. Stem Cells Int,2015,2015:659890.
[30]Vrijsen KR,Maring JA,Chamuleau SA,et al. Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis via EMMPRIN[J]. Adv Healthc Mater,2016,5(19):2555-2565.
[31]Zhao Y,Sun X,Cao W,et al. Exosomes derived from human umbilical cord mesenchymal stem cells relieve acute myocardial ischemic injury[J]. Stem Cells Int,2015,2015:761643.
[32]Wang K,Jiang Z,Webster KA,et al. Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal microRNA-21[J]. Stem Cells Transl Med,2017,6(1):209-222.
[33]Min G,Bin Y,Jingcai W,et al. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis[J]. Oncotarget,2017,8(28):45200-45212.
[34]Gao W,He R,Ren J,et al. Exosomal HMGB1 derived from hypoxia-conditioned bone marrow mesenchymal stem cells increases angiogenesis via the JNK/HIF-1 alpha pathway[J]. FEBS O pen B io,2021,11(5):1364-1373.
[35]Adamiak M,Cheng G,Bobis-Wozowicz S,et al. Induced pluripotent stem cell (iPSC)-derived extracellular vesicles are safer and more efective for cardiac repair than iPSCs[J]. Circ Res,2018,122(2):296-309.
[36]El Harane N,Kervadec A,Bellamy V,et al. Acellular therapeutic approach for heart failure:in vitro production of extracellular vesicles from human cardiovascular progenitors[J]. Eur Heart J,2018,39(20):1835-1847.
[37]Arenaccio C,Chiozzini C,Ferrantelli F,et al. Exosomes in therapy:engineering,pharmacokinetics and future applications[J]. Curr Drug Targets,2019,20(1):87-95.
相似文献/References:
[1]宋菲,综述,俞梦越,等.干细胞来源的外泌体:心肌梗死治疗新启示[J].心血管病学进展,2016,(2):125.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.007]
SONG Fei,YU Mengyue.Exosomes Derived from Stem Cells: Novel Approach in Treatment of
Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(4):125.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.007]
[2]宋林声,综述,陆地,等.低剂量多巴酚丁胺负荷磁共振成像在缺血性心脏病中的应用研究[J].心血管病学进展,2016,(3):285.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.018]
SONG Linsheng,LU Di,ZHAO Xinxiang.Low-dose Dobutamine Stress MRI Myocardial Perfusion and
Assessment of Myocardial Viability[J].Advances in Cardiovascular Diseases,2016,(4):285.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.018]
[3]翟恒博,综述,刘俊,等.缺血性心脏病再认识[J].心血管病学进展,2016,(4):395.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.018]
ZHAI Hengbo,LIU Jun.Rethinking of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(4):395.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.018]
[4]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(4):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[5]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(4):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[6]张伟 木胡牙提.外泌体源性miRNAs在心血管疾病中的研究进展[J].心血管病学进展,2020,(2):111.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.002]
Zhang Wei,Muhuyati.Exogenous miRNAs in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(4):111.[doi:10.16806/j.cnki.issn.1004-3934.2020.02.002]
[7]李一凡 张智伟.巨噬细胞相关的外泌体在心血管疾病中的作用研究进展[J].心血管病学进展,2020,(8):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
LI Yifan,ZHANG Zhiwei.Role of Macrophage-Related Exosomes in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(4):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
[8]施国荣 刘婷婷 田欣 祝自新 郑文荣 王宇峰 孙芳玲 王文.Eph/ephrin信号通路在缺血性心脏病中血管生成中的研究进展[J].心血管病学进展,2021,(2):158.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.016]
Shi Guorong,Liu Tingting,Tian Xin,et al.Research Progress of Eph/ephrin Signaling Pathway in Angiogenesis of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2021,(4):158.[doi:10.16806/j.cnki.issn.1004-3934.2021.02.016]
[9]叶莎 杨翠玲 郑媛媛.骨髓间充质干细胞来源外泌体通过PI3K/Akt途径减轻H2O2诱导心肌细胞损伤[J].心血管病学进展,2022,(3):269.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
YE Sha,YANG Cuiling,ZHENG Yuanyuan.Bone Marrow Mesenchymal Stem Cells Derived Exosomes Attenuate H 2O2 Induced Cardiomyocyte Injury Via PI3K/Akt Pathway[J].Advances in Cardiovascular Diseases,2022,(4):269.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[10]俞佳丽 景雨 张剑 陈楚 陆齐 顾周山 陈子微 周大胜 景宏美 潘丽华.间充质干细胞来源的外泌体在心肌梗死治疗中的研究进展[J].心血管病学进展,2022,(4):341.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.013]
YU JialiJING YuZHANG JianCHEN ChuLU QiGU ZhoushanCHEN ZiweiZHOU DashenJING HongmeiPAN Lihua.Exosomes Derived from Mesenchymal Stem Cells?n the Treatment of Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(4):341.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.013]